| Drug Name |
Dofetilide |
| Drug ID |
BADD_D00701 |
| Description |
Dofetilide is a class III antiarrhythmic agent that is approved by the Food and Drug Administration (FDA) for the maintenance of sinus rhythm in individuals prone to the formation of atrial fibrillation and flutter, and for the chemical cardioversion to sinus rhythm from atrial fibrillation and flutter. |
| Indications and Usage |
For the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm |
| Marketing Status |
approved; investigational |
| ATC Code |
C01BD04 |
| DrugBank ID |
DB00204
|
| KEGG ID |
D00647
|
| MeSH ID |
C063533
|
| PubChem ID |
71329
|
| TTD Drug ID |
D0NW3X
|
| NDC Product Code |
0069-5810; 51862-005; 69452-133; 63190-0670; 42291-413; 42794-044; 51862-125; 14096-192; 29902-0014; 42291-411; 69452-131; 72205-041; 72664-229; 49812-0261; 16714-842; 42794-046; 47335-061; 47335-063; 59651-120; 72603-130; 72603-132; 16714-840; 16729-490; 16729-492; 59651-118; 69539-131; 0069-5820; 69452-132; 72664-231; 0904-6681; 50137-4245; 42291-412; 42794-045; 51862-025; 59651-119; 69539-130; 72664-230; 0904-6682; 0904-6683; 59651-038; 63190-0680; 0069-5800; 72205-040; 42413-0170; 63278-1079; 76055-0013; 16714-841; 16729-491; 69539-132; 72205-039; 72603-131; 69766-022; 47335-062 |
| UNII |
R4Z9X1N2ND
|
| Synonyms |
dofetilide | 1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane | 1-MSPMPE | Tikosyn | UK 68798 | UK-68,798 |
